Vaccine and Infectious Disease Division
VIDD highlights promotions, new hires, honors/awards and goings of its faculty and staff.
The defeatHIV Martin Delany Collaboratory, in collaboration with the Fred Hutchinson Cancer Research Center, the University of Washington Center for AIDS Research (UW CFAR) and the UW Virology Division, are pleased to host the third annual Conference on Cell and Gene Therapy for HIV Cure in Seattle, Washington on August 4-5, 2016. The event will be held on the campus of the Fred Hutchinson Cancer Research Center with VIDD Member Dr. Larry Corey as the keynote speaker.
On June 14, 2016, VIDD Member Dr. Larry Corey, also president and director emeritus of Fred Hutch, was presented with his official portrait.
VIDD Member Dr. Julie McElrath was appointed as the Joel D. Meyers Endowed Chair at the recent 1st Symposium on Infectious Disease in the Immunocompromised Host, which took place at the Seattle Marriot Waterfront Hotel on June 13, 2016.
VIDD Assistant Member Dr. Trevor Bedford named 1 of 22 Pew Charitable Trusts biomedical sciences scholars for early stage career investigators, in the field of virology. Congrats, Trevor!
VIDD Assistant Member Dr. Justin Taylor recently received the 2015 Hartwell Individual Biomedical Research Award for "Providing Life-Long Protection Against Respiratory Syncytial Virus Infection without a Vaccine." The Hartwell Foundation is dedicated to fund early-stage, innovative, and cutting-edge biomedical research to benefit children.
The National Institutes of Health awarded a second five-year round of funding to defeatHIV, a public-private research group based at Fred Hutchinson Cancer Research Center that has spent the last five years investigating the use of genetically modified, HIV-resistant blood stem cells as a potential cure for the virus that causes AIDS. Grant PIs are VIDD Member Dr. Keith Jerome and Fred Hutch's Dr. Hans-Peter Kiem. The grant, which totals over $20 million, also includes VIDD Member Dr. Larry Corey.
Read the full story at Hutch News.
How to reach VIDD News: